Suparna Dutt
Overview
Explore the profile of Suparna Dutt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
983
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Melemenidis S, Nguyen K, Baraceros-Pineda R, Barclay C, Bautista J, Lau H, et al.
bioRxiv
. 2024 Dec;
PMID: 39713317
Background And Objectives: Apheresis platelets products and plasma are essential for medical interventions, but both still have inherent risks associated with contamination and viral transmission. Platelet products are vulnerable to...
2.
Drayson O, Melemenidis S, Katila N, Viswanathan V, Kramar E, Zhang R, et al.
Radiother Oncol
. 2024 Sep;
201:110534.
PMID: 39293721
Background And Purpose: Ultra-high dose-rate radiotherapy (FLASH) has been shown to mitigate normal tissue toxicities associated with conventional dose rate radiotherapy (CONV) without compromising tumor killing in preclinical models. A...
3.
Ashraf M, Melemenidis S, Liu K, Grilj V, Jansen J, Velasquez B, et al.
Int J Radiat Oncol Biol Phys
. 2024 Mar;
120(1):287-300.
PMID: 38493902
Purpose: We conducted a multi-institutional dosimetric audit between FLASH and conventional dose rate (CONV) electron irradiations by using an anatomically realistic 3-dimensional (3D) printed mouse phantom. Methods And Materials: A...
4.
Fu J, Yang Z, Melemenidis S, Viswanathan V, Dutt S, Manjappa R, et al.
Int J Radiat Oncol Biol Phys
. 2024 Jan;
119(3):1001-1010.
PMID: 38171387
Purpose: Ultrahigh-dose-rate (FLASH) irradiation has been reported to reduce normal tissue damage compared with conventional dose rate (CONV) irradiation without compromising tumor control. This proof-of-concept study aims to develop a...
5.
Klett K, Martin-Villa B, Villarreal V, Melemenidis S, Viswanathan V, Manjappa R, et al.
Integr Biol (Camb)
. 2023 Oct;
15.
PMID: 37874173
Radiation therapy, one of the most effective therapies to treat cancer, is highly toxic to healthy tissue. The delivery of radiation at ultra-high dose rates, FLASH radiation therapy (FLASH), has...
6.
Ashraf M, Melemenidis S, Liu K, Grilj V, Jansen J, Velasquez B, et al.
ArXiv
. 2023 Oct;
PMID: 37808098
We conducted a multi-institutional audit of dosimetric variability between FLASH and conventional dose rate (CONV) electron irradiations by using an anatomically realistic 3D-printed mouse phantom. A CT scan of a...
7.
Hongo D, Zheng P, Dutt S, Pawar R, Meyer E, Engleman E, et al.
Front Immunol
. 2021 Nov;
12:746469.
PMID: 34777358
Classical dendritic cells (cDCs) in mice have been divided into 2 major subsets based on the expression of nuclear transcription factors: a CD8Irf8Batf3 dependent (DC1) subset, and a CD8Irf4 (DC2)...
8.
Jensen K, Hongo D, Ji X, Zheng P, Pawar R, Wu T, et al.
Blood Adv
. 2021 Aug;
5(17):3290-3302.
PMID: 34432869
Replacement of failed organs followed by safe withdrawal of immunosuppressive drugs has long been the goal of organ transplantation. We studied changes in the balance of T cells and myeloid...
9.
Mukherjee G, Bag S, Chakraborty P, Dey D, Roy S, Jain P, et al.
PLoS One
. 2020 Nov;
15(11):e0242058.
PMID: 33211709
The tumor immune microenvironment is emerging as a critical player in predicting cancer prognosis and response to therapies. However, the prognostic value of tumor-infiltrating immune cells in Gingivo-Buccal Oral Squamous...
10.
Soto L, Casey K, Wang J, Blaney A, Manjappa R, Breitkreutz D, et al.
Radiat Res
. 2020 Aug;
194(6):618-624.
PMID: 32853385
Radiation therapy, along with surgery and chemotherapy, is one of the main treatments for cancer. While radiotherapy is highly effective in the treatment of localized tumors, its main limitation is...